BioCentury
ARTICLE | Company News

Aegera, Pharmascience deal

June 6, 2011 7:00 AM UTC

Generics company Pharmascience acquired cancer company Aegera. Pharmascience said the acquisition will diversify its R&D activities. Aegera's pipeline include AEG35156, a second-generation antisense ...